Metaxins regulate cancer stem cell-like properties in H1299 cells

Area of Science:

• Mitochondrial protein research
• Cancer biology
• Molecular oncology

Background:

• Lung cancer is a leading cause of cancer mortality with high recurrence and therapy resistance.
• Metaxins (MTX1, MTX2) are outer mitochondrial proteins involved in protein trafficking.
• The role of metaxins in lung cancer remains largely unexplored.

Purpose of the Study:

• To investigate the function of metaxins (MTX1 and MTX2) in lung cancer.
• To determine if metaxins play a role in cancer stem cell maintenance and epithelial-mesenchymal transition (EMT).

Main Methods:

• Lung cancer cells (H1299) were treated with siRNA targeting MTX1 or MTX2.
• Gene and protein expression analyzed via RT-PCR and western blotting.
• Functional assays assessed proliferation, EMT, and stemness markers.

Main Results:

• MTX1 promoter methylation correlated with MTX1 expression levels.
• Knockdown of MTX1 or MTX2 reduced proliferation, EMT, and stemness.
• Overexpression of MTX1 or MTX2 enhanced these cancer-associated properties.
• Metaxins modulated aldehyde dehydrogenase 1 (ALDH1) and other cancer stem cell (CSC) markers.
• MTX1 and MTX2 showed interdependent regulation, cooperating in EMT and stemness.

Conclusions:

• This study provides the first evidence of metaxins' involvement in CSC maintenance in lung cancer.
• MTX1 and MTX2 are potential therapeutic targets for overcoming EMT and stemness in lung cancer patients.